Saule Iskakova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Saule Iskakova has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Marzena Dworacka
Department of Pharmacology, Poznan University of Medical Sciences, Poznan, Poland
6 shared publications - Anna Wesołowska
Department of Pharmacology, Poznan University of Medical Sciences, Rokietnicka 5d, 60-805 Poznań, Poland
5 shared publications - Grzegorz Dworacki
Center for Diagnosis and Treatment of Infertility MedART Poznan Poland
4 shared publications - Agnieszka Stelmaszyk
Department of Pharmacology, Poznan University of Medical Sciences, Poznan, Poland
2 shared publications - Bartosz Adam Frycz
Department of Biochemistry and Molecular Biology, Poznan University of Medical Sciences, Święcickiego 6, 60-781 Poznań, Poland
2 shared publications - Gulmira Zharmakhanova
Department of Natural Science Disciplines, West Kazakhstan Marat Ospanov Medical University, Aktobe
2 shared publications
Latest Publications
- Open Access
- 15 December 2021
- Published by MDPI AG in Biomolecules
- Vol. 11 (12) , 1885
Effects of Low-Dose Atorvastatin on the Peripheral Blood Mononuclear Cell Secretion of Angiogenic Factors in Type 2 Diabetes
The aim of this study was to investigate the influence of statins on the secretion of angiogenesis mediators by the peripheral blood mononuclear cells (PBMCs) derived from patients suffering from type 2 diabetes. The study group comprised 30 participants and included: 10 statin-treated patients with diabetes, 10 statin-free diabetic subjects, and 10 statin-free non-diabetic individuals. PBMCs isolated from the blood were cultured in vitro in standard conditions and in an environment mimicking hyperglycemia. Culture supernatants were evaluated for VEGF, MCP-1, Il-10, and Il-12 by flow cytometry using commercial BDTM. Cytometric Bead Array tests. The secretion of VEGF, MCP-1 and Il-12 by PBMCs, cultured both in standard and hyperglycemic conditions, was significantly lower in the statin-treated patients with type 2 diabetes in comparison with the statin-free diabetic patients. Conversely, the secretion of Il-10 was higher in the statin-treated than in the statin-free diabetic patients. VEGF, MCP-1 and Il-12 levels in PBMCs supernatants from the glucose-containing medium were higher than those from the standard medium in each of the diabetic groups. The results of the study suggest that statins in low doses exhibit an antiangiogenic activity, reducing the secretion of potent proangiogenic factors, such as VEGF and MCP-1, and increasing the secretion of antiangiogenic Il-10 by PBMCs, also under hyperglycemic conditions characteristic for type 2 diabetes.
- 15 December 2021
- Published by MDPI AG in Biomolecules
- Vol. 11 (12) , 1885
Open AccessEffects of Low-Dose Atorvastatin on the Peripheral Blood Mononuclear Cell Secretion of Angiogenic Factors in Type 2 Diabetes
The aim of this study was to investigate the influence of statins on the secretion of angiogenesis mediators by the peripheral blood mononuclear cells (PBMCs) derived from patients suffering from type 2 diabetes. The study group comprised 30 participants and included: 10 statin-treated patients with diabetes, 10 statin-free diabetic subjects, and 10 statin-free non-diabetic individuals. PBMCs isolated from the blood were cultured in vitro in standard conditions and in an environment mimicking hyperglycemia. Culture supernatants were evaluated for VEGF, MCP-1, Il-10, and Il-12 by flow cytometry using commercial BDTM. Cytometric Bead Array tests. The secretion of VEGF, MCP-1 and Il-12 by PBMCs, cultured both in standard and hyperglycemic conditions, was significantly lower in the statin-treated patients with type 2 diabetes in comparison with the statin-free diabetic patients. Conversely, the secretion of Il-10 was higher in the statin-treated than in the statin-free diabetic patients. VEGF, MCP-1 and Il-12 levels in PBMCs supernatants from the glucose-containing medium were higher than those from the standard medium in each of the diabetic groups. The results of the study suggest that statins in low doses exhibit an antiangiogenic activity, reducing the secretion of potent proangiogenic factors, such as VEGF and MCP-1, and increasing the secretion of antiangiogenic Il-10 by PBMCs, also under hyperglycemic conditions characteristic for type 2 diabetes.
- Open Access
- 12 April 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (8) , 1639
Endurance Training Depletes Antioxidant System but Does Not Affect Endothelial Functions in Women with Abdominal Obesity: A Randomized Trial with a Comparison to Endurance-Strength Training
Limited data suggested that inclusion of a strength component into endurance exercises might intensify the beneficial effect of training. However, the available data is limited. Therefore, we aimed to compare the effect of endurance and endurance-strength training on anthropometric parameters, endothelial function, arterial stiffness, antioxidant status, and inflammatory markers in abdominally obese women without serious comorbidities. A total of 101 women were recruited and randomly divided into endurance (n = 52) and endurance-strength (n = 49) groups. During the three-month intervention, both groups performed supervised sixty-minute training three times a week. All studied parameters were measured pre- and post-intervention period. In total, 85 women completed the study. Both training significantly decreased anthropometric parameters. Besides, endurance training decreased endothelial nitric oxide synthase, central aortic systolic pressure, pulse wave velocity, glutathione (GSH), total antioxidant status (TAS), interleukin (IL) 8, matrix metalloproteinase (MMP) 9, and tumor necrosis factor alpha, while endurance-strength training decreased MMP-2 concentrations, and increased IL-6, monocyte chemoattractant protein-1, and MMP-9 levels. We observed significant differences between groups for GSH, TAS, and MMP-9 levels. In summary, endurance and endurance-strength training did not differ in the impact on endothelial function and arterial stiffness. However, endurance training significantly depleted the antioxidant defense, simultaneously reducing MMP-9 levels. The study was retrospectively registered with the German Clinical Trials Register within the number DRKS00019832.
- 12 April 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (8) , 1639
Open AccessEndurance Training Depletes Antioxidant System but Does Not Affect Endothelial Functions in Women with Abdominal Obesity: A Randomized Trial with a Comparison to Endurance-Strength Training
Limited data suggested that inclusion of a strength component into endurance exercises might intensify the beneficial effect of training. However, the available data is limited. Therefore, we aimed to compare the effect of endurance and endurance-strength training on anthropometric parameters, endothelial function, arterial stiffness, antioxidant status, and inflammatory markers in abdominally obese women without serious comorbidities. A total of 101 women were recruited and randomly divided into endurance (n = 52) and endurance-strength (n = 49) groups. During the three-month intervention, both groups performed supervised sixty-minute training three times a week. All studied parameters were measured pre- and post-intervention period. In total, 85 women completed the study. Both training significantly decreased anthropometric parameters. Besides, endurance training decreased endothelial nitric oxide synthase, central aortic systolic pressure, pulse wave velocity, glutathione (GSH), total antioxidant status (TAS), interleukin (IL) 8, matrix metalloproteinase (MMP) 9, and tumor necrosis factor alpha, while endurance-strength training decreased MMP-2 concentrations, and increased IL-6, monocyte chemoattractant protein-1, and MMP-9 levels. We observed significant differences between groups for GSH, TAS, and MMP-9 levels. In summary, endurance and endurance-strength training did not differ in the impact on endothelial function and arterial stiffness. However, endurance training significantly depleted the antioxidant defense, simultaneously reducing MMP-9 levels. The study was retrospectively registered with the German Clinical Trials Register within the number DRKS00019832.
- 1 September 2018
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 143, 245-253
Simvastatin attenuates the aberrant expression of angiogenic factors induced by glucose variability
- 1 September 2018
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 143, 245-253
Simvastatin attenuates the aberrant expression of angiogenic factors induced by glucose variability
- 1 May 2018
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 117, 41-47
New arguments for beneficial effects of alpha-lipoic acid on the cardiovascular system in the course of type 2 diabetes
- 1 May 2018
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 117, 41-47
New arguments for beneficial effects of alpha-lipoic acid on the cardiovascular system in the course of type 2 diabetes
- 1 September 2015
- Published by Springer Nature in Pharmacological Reports
- Vol. 67, 21
The effect of alpha-lipoic acid (ALA) on early stages of atherosclerosis in rats with diabetes
- 1 September 2015
- Published by Springer Nature in Pharmacological Reports
- Vol. 67, 21
The effect of alpha-lipoic acid (ALA) on early stages of atherosclerosis in rats with diabetes
- 1 September 2015
- Published by Springer Nature in Pharmacological Reports
- Vol. 67, 43
Dapagliflozin decreases glycaemic variability and peripheral insulin resistance in rats with diabetes
- 1 September 2015
- Published by Springer Nature in Pharmacological Reports
- Vol. 67, 43
Dapagliflozin decreases glycaemic variability and peripheral insulin resistance in rats with diabetes